Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Committee advances amendment to let Medicaid cover continuous glucose monitors for gestational diabetes amid agency concerns over eligibility language

2336739 · February 18, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Representative Seabolt asked the committee to amend House Bill 352 so Medicaid will cover continuous glucose monitors for gestational diabetes and to remove a requirement that coverage be limited to patients who receive daily insulin.

Representative Seabolt asked a committee to approve an amendment to House Bill 352 (LC570223) that would ensure Medicaid covers continuous glucose monitoring (CGM) when prescribed for people diagnosed with gestational diabetes and would remove a textual requirement that the patient receive “at least 1 daily administration of insulin.”

“This amendment ensures that Medicaid will cover continuous glucose monitoring for pregnant women that are diagnosed with gestational diabetes if their physician prescribes it,” Representative Seabolt said. He argued the change would close an unintended coverage gap.

Brandy Sylvan, director of government relations at the Georgia Department of Community Health, told the…

Already have an account? Log in

Subscribe to keep reading

Unlock the rest of this article — and every article on Citizen Portal.

  • Unlimited articles
  • AI-powered breakdowns of topics, speakers, decisions, and budgets
  • Instant alerts when your location has a new meeting
  • Follow topics and more locations
  • 1,000 AI Insights / month, plus AI Chat
30-day money-back on paid plans